A pilot study assessing patterns of response or resistance to preoperative dose dense docetaxel in women with newly diagnosed breast cancer.

Trial Profile

A pilot study assessing patterns of response or resistance to preoperative dose dense docetaxel in women with newly diagnosed breast cancer.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 01 Sep 2017

At a glance

  • Drugs Docetaxel (Primary) ; Pegfilgrastim
  • Indications Breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Aug 2017 Planned End Date changed from 1 Jun 2016 to 1 Jun 2018.
    • 04 Nov 2016 Planned End Date changed from 1 Jul 2016 to 1 Jun 2016.
    • 11 Apr 2016 Planned End Date changed from 1 Dec 2015 to 1 Jul 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top